Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02724163
Title International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (Myechild01)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Birmingham

myelodysplastic syndrome

myeloid sarcoma

acute myeloid leukemia


Gemtuzumab ozogamicin

Busulfan + Fludarabine


Cytarabine + Fludarabine

Cytarabine + Daunoxome

Busulfan + Cyclophosphamide

Cytarabine + Mitoxantrone

Age Groups: child
Covered Countries FRA

No variant requirements are available.